Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Quadrivalent influenza vaccine immunogenicity and lot-to-lot consistency study in adults and elderly subjects
2014-000785-21Phase 3Completed
- Sponsor
- Sanofi
- Start
- May 2014
- Modality
- Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
Phase 3 trial of influenza vaccine in influenza (4 arms), sponsored by Sanofi. Primary endpoint: Hemagglutinin antibody titers 21 days after vaccination. Started May 2014; status: completed.
02
Drugs
influenza vaccine
03
Conditions
influenza
Beyond the preview
Go deeper on 2014-000785-21.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2014-000785-21.